Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Reveal Pharmaceuticals Inc.
Reveal Pharmaceuticals Inc.
Milton S. Hershey Medical Center
Virginia Commonwealth University
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
Beijing Tiantan Hospital
Abramson Cancer Center at Penn Medicine
NX Development Corp
St. Jude Children's Research Hospital
University of Zurich
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Radiation Therapy Oncology Group
Assistance Publique Hopitaux De Marseille
University of Iowa
Insel Gruppe AG, University Hospital Bern
Saint John's Cancer Institute
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Wake Forest University Health Sciences
University of South Florida
National Institutes of Health Clinical Center (CC)
UNICANCER
Northwestern University
Mahidol University
Mercy Research
NYU Langone Health
Clarity Pharmaceuticals Ltd
RenJi Hospital
SWOG Cancer Research Network
University of California, San Diego
Medical College of Wisconsin
Northwestern University
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
NYU Langone Health
Massachusetts General Hospital
National Cancer Institute (NCI)
University of Utah
Carnegie Mellon University
Jonsson Comprehensive Cancer Center
SWOG Cancer Research Network
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Pediatric Brain Tumor Consortium